Efficacy and Safety of a Joint Health Nutritional Supplement for Subjects with Non-arthritic Knee Joint Pain: A Double-blind, Placebo- and Active-Controlled, Randomized Clinical Trial
Journal of Orthopedic Research and Therapy · 2023
DOI: 10.29011/2575-8241.001272 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Orthopedic Research and Therapy, 2023.
Abstract (Originalsprache)
We evaluated the efficacy and safety of FlexPro MD ® (FP-MD), a combination of krill oil, astaxanthin, and hyaluronic acid, in adults with non-arthritic knee joint pain.This multicenter, double-blind, placebo-and active-controlled study randomized 140 adults 1:1:1 to oral glucosamine hydrochloride/chondroitin sulfate (GC), FP-MD, or placebo once daily for 8 weeks.Mean percentage decreases in clinician-rated WOMAC pain scores were 35% (FP-MD), 21 % (GC), and 20% (placebo) at week 2, and 55% (FP-MD), 35% (GC), and 30% (placebo) at week 8. Overall, the mean percentage decrease in pain was significantly greater (P
Zitieren
APA
(2023). Efficacy and Safety of a Joint Health Nutritional Supplement for Subjects with Non-arthritic Knee Joint Pain: A Double-blind, Placebo- and Active-Controlled, Randomized Clinical Trial. Journal of Orthopedic Research and Therapy. https://doi.org/10.29011/2575-8241.001272
Vancouver
Efficacy and Safety of a Joint Health Nutritional Supplement for Subjects with Non-arthritic Knee Joint Pain: A Double-blind, Placebo- and Active-Controlled, Randomized Clinical Trial. Journal of Orthopedic Research and Therapy. 2023. doi:10.29011/2575-8241.001272
BibTeX
@article{euvimed2023,
title = {Efficacy and Safety of a Joint Health Nutritional Supplement for Subjects with Non-arthritic Knee Joint Pain: A Double-blind, Placebo- and Active-Controlled, Randomized Clinical Trial},
journal = {Journal of Orthopedic Research and Therapy},
year = {2023},
doi = {10.29011/2575-8241.001272}
}
EUVIMED